Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02154568 · ClinicalTrials.gov registry record · NA
Study of Airflow in the Lungs Using Helium MRI
A NA study, sponsored by University of Virginia.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT02154568 is a NA study that has completed, run by University of Virginia. The registered enrollment target is 24 participants.
The verdict
NCT02154568, a NA study, has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
Computer simulations are being developed to predict air flow abnormalities in the airways of patients with lung disease. The purpose of this study is to obtain actual gas flow measurements in the lungs of healthy patients and patients with lung disease and use these measurements to validate the computer models.
Interventions
- DRUG hyperpolarized helium-3 gas with MRI of the chest
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2013-11-07 |
| Est. Completion | 2026-02-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02154568
The ClinicalTrials.gov registry entry for NCT02154568 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which hyperpolarized helium-3 gas with MRI of the chest is the first listed.
NCT02154568 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02154568 about?
NCT02154568 is a clinical study titled "Study of Airflow in the Lungs Using Helium MRI". Computer simulations are being developed to predict air flow abnormalities in the airways of patients with lung disease. The purpose of this study is to obtain actual gas flow measurements in the lungs of healthy patients and patients with lung disease and use these measurements to validate the comp...
What is the current status of trial NCT02154568?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2013-11-07. Estimated completion is 2026-02-26.
What interventions are being tested in trial NCT02154568?
The interventions under investigation include: hyperpolarized helium-3 gas with MRI of the chest (DRUG).
Who is sponsoring clinical trial NCT02154568?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.